Nonclinical Factors are Associated with Long-Term Benzodiazepine Use in Older Adults
White race and size of initial prescription, along with poor sleep quality, are associated with long-term benzodiazepine use in older adults.
Effort to Tackle Overuse of Antipsychotics in Older Adults Backfires
A partnership designed to decrease antipsychotic use in elderly patients may have led to increased use of medications with even worse risk/benefit profiles.
Music Therapy Interventions Reduce Depression Symptoms in Dementia
Therapists can use music to meet the emotional and social needs of individuals with dementia.
Training Nursing Home Staff in Understanding Needs Can Reduce Antipsychotic Use
A new study published in JAMA Internal Medicine, the largest study of its kind, has shown it is possible to reduce the use of antipsychotics in nursing homes, by engaging their staff in a training program designed to target residents’ strengths and their unmet needs.
Veterans with both PTSD and Dementia More Likely to be Prescribed...
Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.
New Medications Fail to Show Efficacy for Alzheimer’s Disease
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed
BPS Releases Review of Alternatives to Antipsychotics
BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics
Antidepressant Use Linked to Dementia
A new study finds that elderly individuals using antidepressants are at significantly higher risk for dementia compared to depressed individuals who did not take the drugs.
Policies to Reduce Antipsychotic use Among Elderly are Failing
Research reveals that rates of antipsychotic prescribing to the elderly in the UK have not dropped despite national recommendations.
Still Mistreating the Elderly with Psychiatric Drugs: Benzodiazepines
Despite safety concerns, a new study reveals that there has been no change in the use of benzodiazepines in the elderly from 2001 to 2010.
HuffPo Features 15 Part DocuSerial on Risperdal Corruption
Huffington Post and journalist Steve Brill have combined to launch a 15 part series about how Johnson & Johnson illegally violated FDA restrictions by pushing the antipsychotic drug, Risperdal, for use with adolescents and the elderly. The series, entitled “America’s Most Admired Lawbreaker,” launched yesterday and will include mixed media, videos, podcasts, source documents, as well as 15 written chapters. Click more for a synopsis of part 1.
My Father-in-law on Risperdal — A Case Study Gets Personal
Risperdal is increasingly used in nursing homes for “agitation,” especially on those suffering from some form of dementia, even when no hallucinations or delusions are observed. Risperdal has quite a long list of side effects including heart problems, metabolic difficulties, diabetes, involuntary movements, agitation, flat affect and sedation. Risperdal has earned a “black box" warning that its use in those with Alzheimer's increases the risk of earlier death. Yet its use in Alzheimer's patients in nursing homes is extremely common.
Seniors More Likely to Get Psych Meds, Less Likely to See...
Seniors are twice as likely to receive psychotropic prescriptions than younger adults but are much less likely to receive mental health care from psychiatrists or to receive psychotherapy, according to a recent study published in the Journal of the American Geriatrics Society. "Our findings suggest that psychotropic medication use is widespread among older adults in outpatient care, at a far higher rate than among younger patients," the study’s lead author Dr. Maust said in a press release. “In many cases, especially for milder depression and anxiety, the safer treatment for older adults who are already taking multiple medications for other conditions might be more therapy-oriented, but very few older adults receive this sort of care."